Protocol No.: CS434-2023-001

Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Intravenous Eravacycline in Children From 8 Years to Less Than 18 Years of Age With Complicated Intra-abdominal Infections (cIAI)
Principal Investigator
Seifarth, Federico
Phase
II
Age Group
Children
Applicable Disease Site
Other
Participating Institutions
Health Sciences Center
West Virginia University
Contact
Robin Hoffer
Phone: +1 724-972-9170

View on ClinicalTrials.gov